|

Apollo Hospitals’ Q4FY24 Performance

ByTeam HUMANITYUAPD

Apollo Hospitals’ Stellar Q4FY24 Performance Apollo Hospitals has recently reported an impressive 76% surge in net profit for Q4FY24, reaching ₹254 crore. This significant uptick is complemented by a 15% year-on-year (YoY) revenue growth, culminating in ₹4,944 crore. This performance highlights the robust operational strategies and effective management decisions driving the company’s success. Let’s explore…

|

Why Tpoxx or Tecovirimat Is the #1 Best Option Now

ByTeam HUMANITYUAPD

What is Tpoxx or Tecovirimat? Tpoxx, also known by its generic name tecovirimat, is an antiviral medication specifically designed to combat infections caused by orthopoxviruses, including smallpox and monkeypox. The primary purpose of Tpoxx is to inhibit the replication of these viruses within the host body, thereby aiding in the management and treatment of infections…